Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study will evaluate the efficacy and safety of adalimumab induction and maintenance treatment in subjects with moderately to severely active Crohn\'s disease in China.
Epistemonikos ID: a5a011967ab57c85db14ac116b61e66956d13b77
First added on: May 12, 2024